| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
2e-11 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
5e-09 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-07 |
| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-07 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
5e-07 |
| mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |